| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |